Shares of GSK plc (GSK), Sanofi (SNY) and Haleon (HLN) are under pressure on Thursday amid increased litigation concerns around the heartburn drug Zantac, which was recalled by the Food and Drug Administration back in 2019. Together, they have… To see the rest of the story go to thefly.com. (See Story Here):(https://www.thefly.com/permalinks/entry.php/id3565733/-Renewed-Zantac-litigation-concerns-sinking-these-bigcap-drugmakers)
previous post